Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRX302 in Benign Prostatic Hyperplasia
NCT01966614Phase 3Completed
- Sponsor
- Sophiris Bio Inc.
- Start
- Oct 2013
- Primary completion
- Dec 2015
- Countries
- 6
01
Overview
A Phase 3 trial of topsalysin in benign prostatic hyperplasia (BPH), sponsored by Sophiris Bio Inc.. Started Oct 2013; status: completed.
02
Drugs
topsalysin
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT01966614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01966614.